Since 2020, back when she was a seventh-year associate, Desmarais LLP partner Kerri-Ann Limbeek, 36, has represented Maryland prenatal testing company Ravgen against some of the giants of the diagnostic industry. That effort has included litigating eight patent infringement cases in district courts across the country, as well as defending the company in 10 inter partes review proceedings before the Patent Trial and Appeal Board.
In 2022, with firm founding partner John Desmarais sitting first chair, Limbeek was part of a trial team that won a $272.5 million verdict for Ravgen against medical testing giant Labcorp. This week, Limbeek, in her first time as acting lead trial counsel, won a $57 million damages verdict for Ravgen against Natera.
